SCHEMBL7548073

SCHEMBL7548073

CC(C)(C)OC(=O)NN(Cc1ccc(-c2ccccc2)cc1)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)C(F)(F)F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MLNR O43193 1/20 0.52
NR1I2 O75469 1/20 0.52
SLCO2B1 O94956 1/20 0.52
ABCB11 O95342 1/20 0.52
ABCB1 P08183 1/20 0.52
UGT1A1 P22309 1/20 0.52
CCKAR P32238 1/20 0.52
OPRK1 P41145 1/20 0.52
GHSR Q92847 1/20 0.52
SLCO1B3 Q9NPD5 1/20 0.52
ABCG2 Q9UNQ0 1/20 0.52
SLCO1B1 Q9Y6L6 1/20 0.52
PSEN1 P49768 11/20 0.51
PSEN2 P49810 11/20 0.51
APH1B Q8WW43 11/20 0.51
NCSTN Q92542 11/20 0.51
APH1A Q96BI3 11/20 0.51
PSENEN Q9NZ42 11/20 0.51
KLK5 Q9Y337 2/20 0.47
CTSS P25774 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6443284 0.95 PSEN1 (0.52) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL6443277 0.95 PSEN1 (0.52) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL6444022 0.91 PSEN1 (0.59) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL6444025 0.91 PSEN1 (0.59) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL6789 0.90 UGT1A1 (0.67) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL6157358 0.90 UGT1A1 (0.67) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL7479726 0.89 PSEN1 (0.46) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL7479722 0.89 PSEN1 (0.46) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL7539884 0.89 PTPN1 (0.51) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL6156316 0.89 UGT1A1 (0.51) MLNRNR1I2SLCO2B1ABCB11ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876336-B1 AZAHEXANE DERIVATIVES AS SUBSTRATE ISOSTERS OF RETROVIRAL ASPARATE PROTEASES NOVARTIS AG (CH) 2002-06-05 EP disclosed
US-6225345-B1 FOR THERAPY OF ACQUIRED IMMUNODEFICIENCY SYNDROME NOVARTIS AG (CH) 2001-05-01 US disclosed